441 related articles for article (PubMed ID: 20634692)
1. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
Holper EM; Addo T
Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
[TBL] [Abstract][Full Text] [Related]
2. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
Sobel BE
Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
Kuller LH
Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
[TBL] [Abstract][Full Text] [Related]
5. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
6. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
[TBL] [Abstract][Full Text] [Related]
7. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
8. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Barsness GW; Gersh BJ; Brooks MM; Frye RL;
Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
[TBL] [Abstract][Full Text] [Related]
9. Recent changes in practice of elective percutaneous coronary intervention for stable angina.
Ahmed B; Dauerman HL; Piper WD; Robb JF; Verlee MP; Ryan TJ; Goldberg D; Boss RA; Phillips WJ; Fedele F; Butzel D; Malenka DJ;
Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):300-5. PubMed ID: 21505155
[TBL] [Abstract][Full Text] [Related]
10. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
11. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of the BARI 2D and COURAGE trials: overview.
Brooks MM; Boden WE; Frye RL
Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
[TBL] [Abstract][Full Text] [Related]
13. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
[TBL] [Abstract][Full Text] [Related]
14. Optimal medical therapy is a proven option for chronic stable angina.
O'Rourke RA
J Am Coll Cardiol; 2008 Sep; 52(11):905-7. PubMed ID: 18772059
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
Weintraub WS; Boden WE; Zhang Z; Kolm P; Zhang Z; Spertus JA; Hartigan P; Veledar E; Jurkovitz C; Bowen J; Maron DJ; O'Rourke R; Dada M; Teo KK; Goeree R; Barnett PG;
Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):12-20. PubMed ID: 20031783
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
Katritsis DG; Ioannidis JP
Circulation; 2005 Jun; 111(22):2906-12. PubMed ID: 15927966
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
Greason KL; Schaff HV
Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113
[TBL] [Abstract][Full Text] [Related]
18. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
[TBL] [Abstract][Full Text] [Related]
19. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
[TBL] [Abstract][Full Text] [Related]
20. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
Tandar A; Boden WE
Curr Opin Cardiol; 2009 Nov; 24(6):591-5. PubMed ID: 19752728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
